Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1996-06-17
1997-09-30
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
562 8, 562 12, 546 21, 546 22, 548412, 548413, 549 5, 549 6, 549216, 549218, A61K 3166, C07F 938, C07F 958, C07F 9572
Patent
active
056725922
ABSTRACT:
The present disclosure relates to dipeptidase inhibitors, and more particularly, to N-Acetylated .alpha.-Linked Acidic Dipeptidase (NAALADase) enzyme inhibitors which are proposed as novel agents for the treatment of prostate cancer. NAALADase is enzyme which is a membrane-bound metalloprotease which hydrolyzes the dipeptide, N-acetyl-L-aspartate-L-glutamate (NAAG) to yield glutamate and N-acetylaspartate. The compounds of the present invention include phosphinic acid derivatives that inhibit NAALADase enzyme activity and which have been found useful for inhibiting the growth of prostate cancer cells.
REFERENCES:
patent: 5489525 (1996-02-01), Pastan
patent: 5500420 (1996-03-01), Maiese
patent: 5538866 (1996-07-01), Israeli et al.
Heston, W.D.W., "Potential Uses of Prostate Specific Membrane Antigen (PMSA): a Neurocarboxypeptidase and Membrane Folate Hydrolase," Urologe
Rothstein, J.D. et al., "Abnormal Excitatory Amino Acid Metabolism in Amyotrophic Lateral Sclerosis," Annals of Neurology, (1990) 28, 18-25.
Subasinghe, N. et al., "Synthesis of Acyclic and Dehydroaspartic Acid Analogoues of Ac-Asp-Glu-OH and Their Inhibition of Rat Brain N-Acetylated .alpha.-Linked Acidic Dipeptidase (NAALA Dipeptidase)," J. of Medicinal Chemistry, (1990) 33:10, 2734-2744.
Tsai, G. et al., "Reductions in acidic amino acids and N-acetylaspartylglutamate in amytrophic lateral scleroses CNS," Brain Research, 556 (1991), 151-156.
Tsai, G. et al., "Immunocytochemical Distribution of N-acetylaspartylglutamate in the Rat Forebrain and Glutamatergic Pathways," J. of Chemical Neuroanatomy, 6 (1993), 277-292.
Bhardwaj, A., "Striatal Nitric Oxide (NO) Production is Enhanced In Focal Cerebral Ischemia: An In Vivo Microdialysis Study," Society for Neuroscience 1996 Abstract Form, (1996).
Hurn, P., "Gender-Linked Injury After Focal Cerebral Ischemia," Society for Neuroscience 1996 Abstract Form, (1996).
Slusher, B., "NAALADase: A Potential Regulator of Synaptic Glutamate," Biotech Update DuPont NEN, (1994) 9:2, 37-39.
Meyeroff, J. et al., "Genetically epilepsy prone rats have increased brain regional activity of an enzyme which liberates glutamate from N-acetyl-aspartyl-glutamate," Brain Research, 593 (1992).
Tsai, G. et al., "Changes of excitatory neurotransmitter metabolism in schizophrenic brains," Salmon Lecturer of the New York Academy of Medicine, (Dec. 2-3, 1993).
Slusher, B.S. et al., "Rat Brain N-Aceylated .alpha.-Linked Acidic Dipeptidase Activity," J. of Biological Chemistry, (1990) 265:34, 21297-21301.
Slusher, B.S. et al., "Immunocytochemical Localization of the N-Acetyl-Aspartyl-Glutamate (NAAG) Hydrolyzing Enzyme N-Acetylated .alpha.-Linked Acidic Dipeptidase (NAALADase)," J. of Comparitive Neurology, (1992) 315, 217-229.
Jackson, P.F. et al., "Design, Synthesis, and Biological Activity of a Potent Inhibitor of the Neuropeptidase N-Acetylated .alpha.-Linked Acidic Dipeptidase," J. of Medicinal Chemistry, (1995) 39:2, 619-622.
Carter, R.E. et al., "Prostate-specific membrane antigen is a hydrolase with a substrate and pharmacologic characteristics of a neuropeptidase," Proc. Natl. Acad. Sci. USA, (1996) 93, 749-753.
Stauch, B.L. et al., "The effects of N-acetylated alpha-linked acidic Neuroscience Letters, (1989) 100, 295-300.
Meyerhoff, J.L. et al., "Activity of a NAAG-hydrolyzing enzyme in brain may affect seizure susceptibility in genetically epilepsy-prone rats," Molecular Neurobiology of Epilepsy, (1992) Chap. 16, 163-172.
Koenig, M.L. et al., "N-acetyl-aspartyl-glutamate (NAAG) elicits rapid increase in intraneuronal Ca.sup.2+ in vitro," NeuroReort, (1994) 5, 1063-1068.
Coyle, J.T. et al., "N-Acetyl-aspartyl Glutamate," Excitatory Amino Acids, (1991) 69-77.
Vornov, J.J., "Toxic NMDA-Receptor Activation Occurs During Recovery in a Tissue Culture Model of Ischemia," J. of Neurochemistry, (1995) 65:4, 1681-1691.
Slusher, B.S., "NAALADase: A Potential Regulator of Synaptic Glutamate," Biotech Update DuPont NEN, (1994) 9:2, 37-39.
Jackson Paul F.
Slusher Barbara S.
Guilford Pharmaceuticals Inc.
Juneau Todd L.
Nath Gary M.
Rotman Alan L.
LandOfFree
Certain phosphonomethyl-pentanedioic acid derivatives thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain phosphonomethyl-pentanedioic acid derivatives thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain phosphonomethyl-pentanedioic acid derivatives thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2256733